Selective Kinase Response Modulators for Healthy Insulin Function
Insinase features selective kinase response modulators (SKRMs)—RIAA and acacia—which have been clinically shown in a preliminary study at the FMRC* to improve fasting insulin and lipid parameters.
- Ground-breaking preliminary research suggests that SKRMs modulate kinase signals in favor of good health
- Designed to modulate kinase signaling (within cells) in favor of healthy insulin function and blood sugar transport
- Balanced kinase signaling helps to maintain healthy blood sugar and triglyceride regulation
- Developed through the ExpresSyn® Process—which combines proteomic research, safety evaluations, and human clinical research to set a new standard of clinical certainty in nutritional supplements
Three tablets daily or as directed by your healthcare provider.
*FMRC (Functional Medicine Research CenterSM) is the clinical research arm of Metagenics.